F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
- Conditions
- Colonoscopy
- Interventions
- Registration Number
- NCT00857272
- Lead Sponsor
- Braintree Laboratories
- Brief Summary
To compare the safety and efficacy of 2 different bowel cleansing preparations prior to colonoscopy in adult subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 308
- Male or female outpatients who are undergoing colonoscopy for a routinely accepted indications:
- At least 18 years of age
- Otherwise in good health, as determined by physical exam and medical history
- If female, and of child-bearing potential, is using an acceptable form of birth control
- Negative urine pregnancy test at screening, if applicable
- In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study
- Subjects with known or suspected ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, or toxic megacolon
- Subjects with impaired consciousness that predisposes them to pulmonary aspiration
- Subjects who are undergoing colonoscopy for foreign body removal and decompression
- Subjects with pre-existing electrolyte disturbances, such as dehydration, or those secondary to the use of diuretics
- Subjects who are taking drugs that may affect electrolyte levels with the exception of routine diuretics
- Subjects with known clinically significant electrolyte abnormalities such as hypernatremia, hyperphosphatemia, hypokalemia, or hypocalcemia
- Subjects who are pregnant or lactating, or intending to become pregnant during the study
- Subjects of childbearing potential who refuse a pregnancy test
- Subjects who are allergic to any preparation components
- Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures
- Subjects who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description HalfLytely with 10mg bisacodyl PEG electrolyte lavage solution + bisacodyl Active control HalfLytely with 5mg bisacodyl PEG electrolyte lavage solution + bisacodyl - reformulation Investigational dose
- Primary Outcome Measures
Name Time Method Efficacy: Percentage of Patients With Successful Preparations Based on a 4 Point Scale during colonoscopy Cleansing was scored with a four point scale used in previous bowel cleansing studies where 4 = "excellent" (no more than small bits of adherent feces/fluid); 3 = "good" (small amounts of feces or fluid not interfering with the exam); 2 = "fair" (enough feces or fluid to prevent a completely reliable exam); 1 = "poor" (large amounts of fecal residue requiring additional cleansing). For the primary efficacy endpoint (preparation success), grades of 4 and 3 were considered a "success" and grades of 2 or 1 were considered a "failure".
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Advanced Clinical Research Institute
🇺🇸Orange, California, United States
Medical Associates Research Group
🇺🇸San Diego, California, United States
Franklin Gastroenterology
🇺🇸Franklin, Tennessee, United States
United Medical Research
🇺🇸New Smyrna Beach, Florida, United States
Maryland Digestive Disease Research
🇺🇸Laurel, Maryland, United States